Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H6N4O |
| Molecular Weight | 126.1166 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=C(N)N=CN1
InChI
InChIKey=DVNYTAVYBRSTGK-UHFFFAOYSA-N
InChI=1S/C4H6N4O/c5-3-2(4(6)9)7-1-8-3/h1H,5H2,(H2,6,9)(H,7,8)
| Molecular Formula | C4H6N4O |
| Molecular Weight | 126.1166 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Adiponectin antagonizes stimulatory effect of tumor necrosis factor-alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5'-monophosphate-activated protein kinase. | 2008-04 |
|
| Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. | 2008-03 |
|
| Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes. | 2007-11 |
|
| Structural insight into AMPK regulation: ADP comes into play. | 2007-10 |
|
| Proteomics analysis of hypothalamic response to energy restriction in dairy cows. | 2007-10 |
|
| AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations. | 2007-09 |
|
| Formamide as the main building block in the origin of nucleic acids. | 2007-08-16 |
|
| Determination of 5-aminoimidazole-4-carboxamide in human plasma by ion-pair extraction and LC-MS/MS. | 2007-08-15 |
|
| 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. | 2007-08 |
|
| Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. | 2007-08 |
|
| Identification of new reference genes for the normalisation of canine osteoarthritic joint tissue transcripts from microarray data. | 2007-07-25 |
|
| Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy. | 2007-07-10 |
|
| A novel function for the N-terminal nucleophile hydrolase fold demonstrated by the structure of an archaeal inosine monophosphate cyclohydrolase. | 2007-05-01 |
|
| Role of glycogen content in insulin resistance in human muscle cells. | 2007-05 |
|
| The role of AMP kinase in diabetes. | 2007-03 |
|
| Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. | 2007-03 |
|
| Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1. | 2007-02-02 |
|
| 5'-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. | 2007-01 |
|
| [Pemetrexed: from preclinic to clinic]. | 2007 |
|
| Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis risk. | 2007 |
|
| Diagnosing AICA-ribosiduria by capillary electrophoresis. | 2006-10-20 |
|
| Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis. | 2006-10 |
|
| Increased ATP-sensitive K+ channel expression during acute glucose deprivation. | 2006-09-29 |
|
| 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. | 2006-09-08 |
|
| Induction of meiotic maturation in mouse oocytes by adenosine analogs. | 2006-09 |
|
| 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. | 2006-08-15 |
|
| Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. | 2006-08 |
|
| AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. | 2006-07 |
|
| Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. | 2006-06 |
|
| Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. | 2006-06 |
|
| α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle. | 2006-03 |
|
| AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. | 2006-02-03 |
|
| Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. | 2006-02 |
|
| Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. | 2006-01 |
|
| Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. | 2006 |
|
| AMP-activated protein kinase and type 2 diabetes. | 2006 |
|
| A role for hypothalamic malonyl-CoA in the control of food intake. | 2005-12-02 |
|
| Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. | 2005-10-14 |
|
| 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. | 2005-07-01 |
|
| AICAR suppresses IL-2 expression through inhibition of GSK-3 phosphorylation and NF-AT activation in Jurkat T cells. | 2005-07-01 |
|
| Exercise-induced increase in muscle insulin sensitivity. | 2005-07 |
|
| The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. | 2005-06-16 |
|
| Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. | 2005-06 |
|
| Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. | 2005-05-27 |
|
| Increased potency and efficacy of combined phosphorylase inactivation and glucokinase activation in control of hepatocyte glycogen metabolism. | 2005-03 |
|
| MEK inhibitors block AICAR-induced maturation in mouse oocytes by a MAPK-independent mechanism. | 2005-02 |
|
| Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors. | 2004-12-30 |
|
| The role of AMP-activated protein kinase in the action of ethanol in the liver. | 2004-12 |
|
| Mapping of the bovine genes of the de novo AMP synthesis pathway. | 2004-12 |
|
| Aryl and heterocyclic diazo compounds as potential environmental electrophiles. | 1977-05 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:24:24 GMT 2025
by
admin
on
Mon Mar 31 18:24:24 GMT 2025
|
| Record UNII |
3V0Y2PDE6K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
79679-7
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
||
|
LOINC |
79652-4
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
||
|
LOINC |
79672-2
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9679
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY | |||
|
2030
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY | |||
|
3V0Y2PDE6K
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY | |||
|
7784
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY | |||
|
360-97-4
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY | |||
|
DTXSID8059891
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY | |||
|
206-641-4
Created by
admin on Mon Mar 31 18:24:24 GMT 2025 , Edited by admin on Mon Mar 31 18:24:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> METABOLITE | |||
|
|
PARENT -> METABOLITE INACTIVE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|